SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010003
Filing Date
2017-05-10
Accepted
2017-05-09 19:01:18
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20170331.htm 10-Q 1608157
2 EX-31.1 sage-ex311_6.htm EX-31.1 9112
3 EX-31.2 sage-ex312_8.htm EX-31.2 9070
4 EX-32.1 sage-ex321_7.htm EX-32.1 10907
5 GRAPHIC g20170509184343368217.jpg GRAPHIC 82979
  Complete submission text file 0001564590-17-010003.txt   5621827

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sage-20170331.xml EX-101.INS 1225752
7 XBRL TAXONOMY EXTENSION SCHEMA sage-20170331.xsd EX-101.SCH 38933
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20170331_cal.xml EX-101.CAL 36228
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20170331_def.xml EX-101.DEF 127229
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20170331_lab.xml EX-101.LAB 282223
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20170331_pre.xml EX-101.PRE 226597
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 17827996
SIC: 2834 Pharmaceutical Preparations